Steven Fox, MD, MSc

Recent Work

• 

  Approving the Pfizer Vaccine Would, Finally, Mark the End of the Beginning

  The news from Pfizer suggests we may be at the end of the beginning of the pandemic. We now have even more reason to redouble our pandemic control and mitigation efforts, so that we can limit the disability and death from new infections until vaccines become available.

  By Steven Fox, MD, MSc

  Categorized in

  • Evidence Base

• Impact of Early Initiation of Antihypertensive Medications for Patients with Hypertension or Elevated Blood Pressure

  Initiating antihypertensive medications before experiencing a cardiovascular disease-related clinical event was associated with reduced risk of AMI, stroke and death for all hypertensive patients identified in the new guidelines.

  Categorized in

  • Research
  • Journal Articles

• The Impact of Delayed Hepatitis C Viral Load Suppression on Patient Risk: Historical Evidence from the Veterans Administration

  While the high cost of new hepatitis C treatments has resulted in “watchful waiting” strategies to safely delay treatment, this study found that this approach delays viral load suppression and negatively impacts patient risk for adverse events and death.

  Categorized in

  • Research
  • Journal Articles